The study, which spanned more than a decade, found adults who took 600 milligrams of aspirin daily for at least two years were 63 percent less likely to develop colorectal cancer. All participants were carriers of Lynch syndrome, a genetic condition that predisposes a person to developing certain type of cancers. Although aspirin reduced the risk for developing colorectal cancer, researchers found a similar number of polyps in both groups.
Related Articles on Colorectal Cancer:
Trial Shows First Evidence Anal Cancer is Preventable
Study: Signet Cell Histology Five Times More Likely in Rectal Cancer Patients Under 40
Link Between Colon Cancer and Hot Dogs Questioned
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
